Pakistan has approved emergency use of China’s CanSinoBIO COVID-19 vaccine to tackle the spread of novel virus in the country.
As per details, Drug Regulatory Authority of Pakistan (DRAP) has approved the use of CanSinoBIO COVID-19 vaccine developed by China.
The CanSinoBIO vaccine will be administered to people via a single dose.
The development comes as AJM Pharma (Pvt) Limited had sought DRAP’s approval for the use of CanSinoBIO vaccine in Pakistan.
It is to be noted that Dr Faisal Sultan – SAPM on Health, had apprised that the clinical trials of China’s CanSinoBIO vaccine in Pakistan had proved to be 74.8% effective against symptomatic coronavirus patients, whereas the vaccine proved 100% effective in preventing severe disease.
Meanwhile, DRAP approved Russia’s Sputnik V COVID-19 vaccine for emergency use under Section VII of Drug Act 1976 of Pakistan on February 6th last week.
It is pertinent to know that Pakistan had launched COVID-19 vaccination drive on February 3rd after China donated 500,000 Sinopharm COVID-19 vaccine doses.
